An investigation of the cause of accumulation of verapamil during regular dosing in patients.
about
Pharmacokinetics and pharmacodynamics of two formulations of verapamil.Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.Acute verapamil toxicity in a patient with chronic toxicity: possible interaction with ceftriaxone and clindamycin.The effect of oral verapamil therapy on antipyrine clearance.Serum binding of nifedipine and verapamil in patients with ischaemic heart disease on monotherapy.Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.Verapamil pharmacokinetics.Effect of verapamil on splanchnic haemodynamics in a portal hypertensive rat model.
P2860
Q34417142-84B98F81-01F7-4B99-B06A-157336F63926Q38216387-6CF43ACE-E025-41CC-B688-63DA30459142Q40842338-5753985C-4561-46E4-A844-DA2671D79F0EQ42231825-1F176DDF-0537-4F90-9723-B5DDA6BA82F0Q43222574-A4362BED-FC42-44D7-8CE7-4C3F4ADE8175Q46511734-DDC846DE-A0DB-475C-BA50-96D801AFA09CQ46530481-AFC7E32A-0523-4BCC-A6FB-40481476A560Q54329944-6C093C69-32DA-4676-8323-FF13ECA6CF26
P2860
An investigation of the cause of accumulation of verapamil during regular dosing in patients.
description
1985 nî lūn-bûn
@nan
1985 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
An investigation of the cause ...... ng regular dosing in patients.
@ast
An investigation of the cause ...... ng regular dosing in patients.
@en
An investigation of the cause ...... ng regular dosing in patients.
@nl
type
label
An investigation of the cause ...... ng regular dosing in patients.
@ast
An investigation of the cause ...... ng regular dosing in patients.
@en
An investigation of the cause ...... ng regular dosing in patients.
@nl
prefLabel
An investigation of the cause ...... ng regular dosing in patients.
@ast
An investigation of the cause ...... ng regular dosing in patients.
@en
An investigation of the cause ...... ng regular dosing in patients.
@nl
P2093
P2860
P1476
An investigation of the cause ...... ng regular dosing in patients.
@en
P2093
A A Taylor
D R Abernethy
J B Schwartz
J R Mitchell
P2860
P304
P356
10.1111/J.1365-2125.1985.TB02678.X
P407
P577
1985-04-01T00:00:00Z